[1] Monitoring recommendations for patients using both medications include: Regular blood glucose testing particularly post-lunch and early evening when morning prednisolone is used Consider action if readings are persistently above 12 mmol/L (with individualisation based on your care plan) HbA1c measurement every 3 months for patients with diabetes or prediabetes Fasting glucose checks if not previously diabetic, particularly during corticosteroid therapy Symptom awareness for hyperglycaemia (increased thirst, frequent urination, fatigue, blurred vision) Patients with established diabetes may require adjustments to their glucose-lowering regimen whilst on prednisolone
Tamoxifen versus Placebo in the Treatment of Peyronie's Disease
No data on effects on breastfed infants
Doctronic.ai helps patients understand their diagnoses before they even reach a billing specialist, creating better-informed healthcare consumers
Plant-based diets, such as the MIND diet, are associated with increased levels of a protein called sex-hormone binding globulin (SHBG)
What makes Retatrutide different from GLP-1 or dual agonist peptides
